Recent News

Assessment of AI related activities under the R&D Tax Incentive and potentially emerging compliance focuses

August 12th, 2024

Artificial Intelligence (AI) has been a hot topic in recent years with more companies seeking to utilise the technology in order to capitalise on gains in capability and efficiency. Increasing numbers of companies are investing in AI developments and anecdotally, this probably means an increasing number of companies submitting claims for AI related developments under the R&D Tax Incentive. However, whilst AI is a relatively new and developing field, companies need to be careful not to assume that projects involving […]

Read More

AusIndustry Changes to Advance and Overseas Finding R&D Application Forms

July 29th, 2024

Companies seeking to claim expenditure for overseas activity incurred by an Australian company under the R&D Tax Incentive must apply separately to claim these costs by first lodging an Overseas Finding Application with AusIndustry. Also, companies seeking AusIndustry’s view on eligibility of activities can lodge an Advance Finding Application with AusIndustry. Ausindustry have announced this week that an updated version of the Advance and Overseas Finding (AOF) form is now available through the R&D Tax Incentive customer portal. All  applicants are now required to […]

Read More

Swanson Reed presenting R&D Tax update at MSIA Event – July 2024

July 15th, 2024

Swanson reed is providing an update on the R&D Tax Incentive at an event on Thursday, July 25th, 2024 in Brisbane presented by MSIA (Medical Software Industry Association). The 2024 MSIA Brisbane event is being held in conjunction with the Australian Digital Health Agency (ADHA) to provide a full day of updates and insights in Digital Health. Swanson Reed’s update will provide an update on R&D Tax including insight into current policy discussions leading into the upcoming review of Australia’s […]

Read More

Significant Refundable R&D Offsets receipts reported to the ASX in recent months

July 8th, 2024

Over recent months, a number of companies have reported to the ASX receipt of substantial Refundable R&D Tax Offsets. Notable receipts include: Recce Pharmaceuticals (ASX: RCE) received $2.6 M related to its anti-infective platform; Latrobe Magnesium (ASX: LMG) received $12.5 M related to Magnesium extraction technology; Group 6 Metals (ASX:G6M) received $14.3 M related to processes for producing higher value tungsten products Orthocell Limited (ASX: SNT) received $3.05 M related to its mobility regeneration technology; Botanix (ASX: BOT) received $3 […]

Read More

Categories

Archives